Divya Anjana Shankar, MD

Clinical Instructor, Medicine

Divya Anjana Shankar
617.358.2800

Biography

Divya Anjana Shankar, MD is a fellow at the Boston University Pulmonary Center. In 2017, she graduated from Chobanian and Avedisian School of Medicine and went on to complete the Boston Medical Center Internal Medicine Residency Program.

Other Positions

  • Fellow, Pulmonary & Critical Care Medicine, Boston Medical Center

Publications

  • Published on 6/27/2024

    Homer-Bouthiette C, Shen BH, Dobie AC, Shankar DA, Pang B, Law AC, Bosch NA. Practice Patterns for Acute Asthma Exacerbation in Adult Patients Admitted to US Intensive Care Units. Ann Am Thorac Soc. 2024 Jun 27. PMID: 38935672.

    Read at: PubMed
  • Published on 6/1/2024

    Kearney CM, Sangani R, Shankar D, O'Connor GT, Law AC, Walkey AJ, Bosch NA. Comparative Effectiveness of Mepolizumab, Benralizumab, and Dupilumab among Patients with Difficult-to-Control Asthma: A Multicenter Retrospective Propensity-matched Analysis. Ann Am Thorac Soc. 2024 Jun; 21(6):866-874. PMID: 38241013.

    Read at: PubMed
  • Published on 1/1/2024

    Shankar DA, Hawkins F, Alysandratos KD, Wilson KC, Walkey AJ, Bosch NA, Law AC. Uptake of Antifibrotics for Patients with Idiopathic Pulmonary Fibrosis: 2016-2022. Ann Am Thorac Soc. 2024 Jan; 21(1):170-173. PMID: 37879035.

    Read at: PubMed
  • Published on 6/1/2023

    Pang B, Kearney L, Maccarone J, Zhang J, Kearney C, Sangani R, Shankar DA, Gillmeyer KR, Law AC, Bosch NA. Association between Early Venous Thromboembolism Prophylaxis, Bleeding Risk, and Venous Thromboembolism among Critically Ill Patients with Thrombocytopenia. Ann Am Thorac Soc. 2023 Jun; 20(6):917-920. PMID: 36867519.

    Read at: PubMed
  • Published on 4/15/2023

    Mesfin N, Sangani R, Shankar DA, Reardon C. New Frontiers in Therapeutics for Interstitial Lung Diseases. Am J Respir Crit Care Med. 2023 Apr 15; 207(8):1089-1091. PMID: 36735934.

    Read at: PubMed
  • Published on 4/3/2023

    Shankar DA, Bosch NA, Walkey AJ, Law AC. Practice Changes Among Patients Without COVID-19 Receiving Mechanical Ventilation During the Early COVID-19 Pandemic. Crit Care Explor. 2023 Apr; 5(4):e0889. PMID: 37025306.

    Read at: PubMed
  • Published on 4/1/2023

    Shankar DA, Walkey AJ, Hawkins FJ, Bosch NA, Peterson D, Law AC. Hospital-level variation in practices and outcomes for patients with severe acute exacerbations of idiopathic pulmonary fibrosis: a retrospective multicentre cohort study. BMJ Open Respir Res. 2023 Apr; 10(1). PMID: 37076251.

    Read at: PubMed
  • Published on 9/1/2022

    Kathuria H, Shankar D, Cobb V, Newman J, Bulekova K, Werntz S, Borrelli B. Integrating Social Determinants of Health With Tobacco Treatment for Individuals With Opioid Use Disorder: Feasibility and Acceptability Study of Delivery Through Text Messaging. JMIR Form Res. 2022 Sep 01; 6(9):e36919. PMID: 36048509.

    Read at: PubMed
  • Published on 4/6/2022

    Shankar D, Borrelli B, Cobb V, Quintiliani LM, Palfai T, Weinstein Z, Bulekova K, Kathuria H. Text-messaging to promote smoking cessation among individuals with opioid use disorder: quantitative and qualitative evaluation. BMC Public Health. 2022 Apr 06; 22(1):668. PMID: 35387648.

    Read at: PubMed
  • Published on 4/1/2020

    Bhat S, Altajar S, Shankar D, Zahorian T, Robert R, Qazi T, Shah B, Farraye FA. Process and Clinical Outcomes of a Biosimilar Adoption Program with Infliximab-Dyyb. J Manag Care Spec Pharm. 2020 Apr; 26(4):410-416. PMID: 32223602.

    Read at: PubMed

View 1 more publications: View full profile at BUMC

View all profiles